SCHEMBL4487377

SCHEMBL4487377

COc1ccc(CNC(=O)C(C#N)=CC=Cc2ccc(O)c(O)c2)cc1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.70
EGFR P00533 5/20 0.64
ERBB2 P04626 2/20 0.54
DNM1 Q05193 2/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
NSD2 O96028 1/20 0.53
IDE P14735 1/20 0.53
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 3/20 0.52
MAPT P10636 2/20 0.52
MCL1 Q07820 1/20 0.52
EEF2K O00418 1/20 0.52
PLK4 O00444 1/20 0.52
PIM1 P11309 1/20 0.52
AXL P30530 1/20 0.52
MAPKAPK2 P49137 1/20 0.52
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
IRAK1 P51617 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4487372 1.00 MAOB (0.70) MAOBEGFRERBB2DNM1MEN1
SCHEMBL13678250 0.92 MAOB (0.67) MAOBEGFRERBB2DNM1MEN1
SCHEMBL13678103 0.92 MAOB (0.67) MAOBEGFRERBB2DNM1MEN1
SCHEMBL4475751 0.91 MAOB (0.68) MAOBEGFRERBB2DNM1MEN1
SCHEMBL4475745 0.91 MAOB (0.68) MAOBEGFRERBB2DNM1MEN1
SCHEMBL13678248 0.90 MAOB (0.70) MAOBEGFRERBB2DNM1MEN1
SCHEMBL13678407 0.90 MAOB (0.70) MAOBEGFRERBB2DNM1MEN1
SCHEMBL4487080 0.89 MAOB (0.83) MAOBEGFRERBB2DNM1MEN1
SCHEMBL4487075 0.89 MAOB (0.83) MAOBEGFRERBB2DNM1MEN1
SCHEMBL3437189 0.87 MAOB (0.63) MAOBEGFRERBB2DNM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAOB 3511/4885EGFR 1713/4885ERBB2 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.